Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3526
CALL
Danaher
DHR
$155B
| $672K | ﹤0.01% |
+3,400
| New | +$659K |
2025 Q2
0 quarters
|
|
3527
FRP Holdings
FRPH
$388M
| $671K | ﹤0.01% |
24,960
+6,572
| +36% | +$178K |
2016 Q2
36 quarters
|
|
3528
CEMIG Preferred Shares
CIG
$6.81B
| $671K | ﹤0.01% |
+342,338
| New | +$626K |
2025 Q2
0 quarters
|
|
3529
Unisys
UIS
$170M
| $669K | ﹤0.01% |
147,655
+48,588
| +49% | +$218K |
2013 Q2
48 quarters
|
|
3530
Vanguard International Dividend Appreciation ETF
VIGI
$8.81B
| $669K | ﹤0.01% |
7,420
+300
| +4% | +$25.9K |
2023 Q4
6 quarters
|
|
3531
Ero Copper
ERO
$4.02B
| $668K | ﹤0.01% |
39,645
-6,287
| -14% | -$84.9K |
2023 Q2
8 quarters
|
|
|
MBX
3532
MBX Biosciences
MBX
$2.8B
| $668K | ﹤0.01% |
58,541
+46,723
| +395% | +$476K |
2024 Q3
3 quarters
|
|
3533
Xponential Fitness
XPOF
$195M
| $667K | ﹤0.01% |
89,041
+21,299
| +31% | +$176K |
2022 Q1
13 quarters
|
|
3534
Heron Therapeutics
HRTX
$68M
| $665K | ﹤0.01% |
321,424
+138,878
| +76% | +$284K |
2014 Q2
44 quarters
|
|
3535
NWPX Infrastructure Inc
NWPX
$1.03B
| $665K | ﹤0.01% |
16,205
+6,362
| +65% | +$256K |
2016 Q4
34 quarters
|
|
3536
Fortis
FTS
$26.9B
| $664K | ﹤0.01% |
13,921
+13,222
| +1,892% | +$630K |
2017 Q1
33 quarters
|
|
|
NXH
3537
Neighborhood Intelligence Inc
NXH
$195M
| $664K | ﹤0.01% |
106,186
+53,266
| +101% | +$258K |
2013 Q2
48 quarters
|
|
3538
Olema Pharmaceuticals
OLMA
$718M
| $664K | ﹤0.01% |
155,840
+2,736
| +2% | +$12.2K |
2022 Q1
13 quarters
|
|
3539
Certara
CERT
$1.49B
| $663K | ﹤0.01% |
56,660
-3,445
| -6% | -$40.8K |
2022 Q1
13 quarters
|
|
3540
Capital Bancorp
CBNK
$653M
| $662K | ﹤0.01% |
19,718
+10,500
| +114% | +$322K |
2018 Q4
26 quarters
|
|
3541
Carter Bankshares
CARE
$706M
| $661K | ﹤0.01% |
38,136
+15,241
| +67% | +$241K |
2022 Q1
13 quarters
|
|
|
NXDR
3542
Nextdoor Holdings
NXDR
$952M
| $660K | ﹤0.01% |
397,643
+183,982
| +86% | +$278K |
2023 Q2
8 quarters
|
|
3543
CALL
Cisco
CSCO
$444B
| $659K | ﹤0.01% |
+9,500
| New | +$584K |
2025 Q2
0 quarters
|
|
3544
Invesco S&P 500 Low Volatility ETF
SPLV
$6.99B
| $659K | ﹤0.01% |
9,050
+750
| +9% | +$54.3K |
2023 Q4
6 quarters
|
|
3545
OppFi
OPFI
$518M
| $659K | ﹤0.01% |
47,098
+26,481
| +128% | +$298K |
2022 Q2
12 quarters
|
|
3546
CALL
Bloomin' Brands
BLMN
$690M
| $659K | ﹤0.01% |
+76,500
| New | +$614K |
2025 Q2
0 quarters
|
|
|
JKS
3547
JinkoSolar
JKS
$475M
| $655K | ﹤0.01% |
30,876
-2,614
| -8% | -$47.5K |
2013 Q2
48 quarters
|
|
|
FOLD
3548
PUT
DELISTED
Amicus Therapeutics
FOLD
| $653K | ﹤0.01% |
114,000
-32,400
| -22% | -$209K |
2024 Q3
3 quarters
|
|
|
EBTC
3549
DELISTED
Enterprise Bancorp
EBTC
| $653K | ﹤0.01% |
16,477
+6,545
| +66% | +$250K |
2016 Q3
35 quarters
|
|
3550
ATN International
ATNI
$431M
| $653K | ﹤0.01% |
40,158
+6,309
| +19% | +$103K |
2016 Q2
36 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.